
India Glycols receives EIR from USFDA for nutraceuticals products and dietary supplements ingredients at Dehradun plant
India Glycols Limited (IGL) has achieved a significant milestone by receiving the Establishment Inspection Report (EIR) with no observations from the U.S. Food and Drug Administration (USFDA) on April 24, 2025. This recognition is for the company’s …